Presentations, Chairing, Reviewing

Golden-microphoneInvited Presentations

  • 2016 Global Forum on Hereditary Angioedema, Warsaw, Poland
  • 2016 SFB TR84 seminar “Innate Immunity of the Lung”, Giessen, Germany
  • 2016 ECAT Foundation Symposium, Leiden, the Netherlands
  • 2016 2nd German Congress of Laboratory Medicine, Mannheim, Germany
  • 2016 Third HAWK Consensus Conference, Gargnano, Italy
  • 2016 4th Bradykinin Meeting, Berlin, Germany
  • 2016 3rd Maastricht Summerschool on Thrombin Generation, Maastricht, the Netherlands
  • 2016 EAACI Congress (Shire Symposium), Vienna, Austria
  • 2016 60th SSC of the ISTH, Montpellier, France
  • 2016 AMSTOL Symposium, Amsterdam
  • 2015 Global Forum on Hereditary Angioedema, Madrid, Spain
  • 2015 HAEA International Scientific Meeting on Hereditary Andioedema with Normal C1 inhibitor, Falls Church, USA
  • 2015 EAACI Congress, Barcelona, Spain
  • 2015 HAE Spring Meeting, Amsterdam, the Netherlands
  • 2014 3rd Bradykinin Symposium, Berlin, Germany
  • 2014 59th SSC of the ISTH, Milwaukee, USA
  • 2014 XXVII International Society for Laboratory Hematology, The Hague, the Netherlands
  • 2014 7th Expert Clotters Meeting, Birmingham, UK
  • 2013 Bayer Hemofilia Awards Program Ceremony, Amsterdam, the Netherlands
  • 2013 8th C1-Inhibitor Deficiency Workshop, held in Budapest, Hungary
  • 2013 Nordic Bradykinin workshop held in Copenhagen, Denmark
  • 2012 Kinin Meeting, held in Paris, France
  • 2012 2nd Thrombin Meeting, held in Maastricht, the Netherlands
  • 2012 58th SSC of the ISTH, Liverpool, UK

Reviewing

  • Journals: Blood, ATVB (Arteriosclerosis, Thrombosis, and Vascular Biology), Journal of Thrombosis and Haemostasis, Thrombosis and Haemostasis, eLife, FEBS Journal, Clinical Biochemistry, PLoS ONE, Thrombosis Journal, Thrombosis Research, Haemophilia, Blood Coagulation and Fibrinolysis, Journal of Immunological Methods, International Journal of Nanomedicine, British Journal of Pharmacology, Journal of Basic and Clinical Physiology and Pharmacology, Scientific Reports, Platelets, Allergy, Asthma & Clinical Immunology, Journal of Immunological Methods, Journal of Clinical Laboratory Analysis
  • Funding Agencies: The Netherlands Heart Foundation (NHF), Thrombosis Foundation Holland (TFN), International Patient Organization for C1 inhibitor Deficiencies (HAEi)

Editorial work
• 2016 Editorial Board – Journal of Thrombosis and Haemostasis
• Review Editor for Frontiers in Medicine – Hematology

Scientific Committees
•
2013 XXIV ISTH Scientific Subcommittee: Inflammation and Immunity

Chairing

  • 2016 Third HAWK Consensus Conference, Gargnano, Italy (September)
  • 2016 EAACI Congress (Shire Symposium), Vienna, Austria
  • 2015 EAACI, Barcelona, Spain. Poster session Angioedema
  • 2015 HAE Spring meeting, Amsterdam, the Netherlands
  • 2015 NVTH Symposium Koudekerke, the Netherlands. Session Chair
  • 2013 XXIV ISTH, Amsterdam, the Netherlands: Session Chair: Novel Platelet Inhibitors
  • 2012 NVTH Symposium Koudekerke, the Netherlands. Session Chair
  • 2013 8th C1-Inhibitor Deficiency Workshop, Budapest, Hungary. Session Chair
  • 2010 Joint meeting of the NVTH and GTH, Nurnberg. Session Chair: Contact Activation
  • 2009 XXII ISTH Conference, Boston, USA. Session Chair: Factor XI and the contact system

Accepted abstracts for oral presentation at international conferences (not updated after 6-2014)
2014 ISFP, Marseille
• Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy
Claudia Tersteeg, Steven de Maat, Simon F. De Meyer, Michel W.J. Smeets, Arjan D. Barendrecht, Mark Roest, Gerard Pasterkamp, Rob Fijnheer, Karen Vanhoorelbeke, Philip. G. de Groot and Coen Maas

2014 GTH, Vienna
• Mutations in Factor XII that cause angioedema enhance its susceptibility to activation by plasmin.
Steven de Maat, Sanne van Dooremalen, Marta Mansi, Marco Cicardi, Philip G. de Groot, Coen Maas

• Plasmin Cleavage of von Willebrand Factor as an Emergency Bypass for ADAMTS13 Deficiency in Thrombotic Microangiopathy
Claudia Tersteeg, Steven de Maat, Simon F. De Meyer, Michel W.J. Smeets, Arjan D. Barendrecht, Mark Roest, Gerard Pasterkamp, Rob Fijnheer, Karen Vanhoorelbeke, Philip. G. de Groot and Coen Maas

2013 XXIV ISTH, Amsterdam
• Endocannabinoids limit collagen-induced platelet activation and restrict aggregate formation under flow
Valentina De Angelis, Arnold Koekman, Mark Roest, Cees Weeterings, Philip G. de Groot, Coen Maas

• Two cleavage sites in factor XII direct its diverging activities
Steven de Maat, Dennis Beringer, Loes Kroon-Batenburg, Philip de Groot, Coen Maas

• A nanobody-based method for tracking factor XII activation in plasma
Steven de Maat, Sanne van Dooremalen, Philip de Groot, Coen Maas

• Plasmin cleavage of von Willebrand factor; a physiological and therapeutic bypass for ADAMTS13 deficiency and thrombotic microangiopathy
Claudia Tersteeg, Michel Smeets, Mark Roest, Gerard Pasterkamp, Philip de Groot, Coen Maas

2011 XXIII ISTH Kyoto
• Activated factor XII enhances thrombus formation independent of its role in coagulation
Maas C, Urbanus RT, den Hartogh SC, Weeterings C, Sebastian SAE and de Groot PG

• Functions of plasma kallikrein for thrombosis and vascular leakage in vivo
Maas C, Oschatz C and Renne T

• Mast cell-heparin increases vascular permeability in vivo by contact system-driven bradykinin formation
Oschatz CT, Maas C, Bjorkqvist J, Mueller-Esterl W, Wuillemin WA and Renne T

2009 XXII ISTH Boston
• Immune responses against domain I of β2GPI are dependent on protein conformation
B. de Laat, C. Zappelli, M. van Berkel, B. Siregar, P. de Groot, K. Mertens, M. Gebbink, C. Maas

• Factor V is a cofactor for activation of Factor XI by thrombin
C. Maas, J. C. M. Meijers, C. Weeterings, P. G. de Groot, R. T. Urbanus

• Misfolded proteins activate Factor XII in humans, leading to kallikrein formation without initiating coagulation
C. Maas, J. W. P. Govers-Riemslag, B. Bouma, B. Schiks, B. P. C. Hazenberg, H. M. Lokhorst, P. Hammarstrom, H. ten Cate, P. G. de Groot, B. N. Bouma, M. F. B. G. Gebbink

2008 ISFP, Vienna
The kallikrein-kinin system, but not coagulation, is activated by interaction of FXII with misfolded proteins
C. Maas

2007 XXI ISTH, Geneva
The use of tissue-type plasminogen activator to detect misfolded proteins in biopharmaceuticals
C. Maas, M. F. B. G. Gebbink, B. Bouma, S. Hermeling, W. Jiskoot